At a glance
ClinicalIndex Comparison RecordStandardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Randomized Controlled Trial of Vitamin D Repletion Regimens in Primary Hyperparathyroidism
In Brief
A Phase 4 clinical trial evaluating 10,000 IU Vitamin D3, Placebo, and 1 other intervention for Primary Hyperparathyroidism and Vitamin D Deficiency. Completed, enrolled 9 participants across 1 site.
Detailed Summary
This study will look at the effect of 2 treatment regimens that contain vitamin D in a six-month treatment trial of patients with PHPT who are vitamin D deficient. Patients will be assigned randomly to one of 2 regimens, and will be followed with tests of their blood, urine and bones. This study should provide important information on the effect of vitamin D therapy in patients with PHPT. In addition, data from this study will guide physicians as to how best to treat their patients who have PHPT and vitamin D deficiency.
Study Details
Timeline
Interventions
Month 1: 20,000 IU vitamin D3 once a week Months 2-6: 10,000 IU vitamin D3 once a week
Month 1: Placebo once a week Months 2-6: Placebo once a week
Daily multivitamin with 400 IU vitamin D.